All shareholders of record owning USEI common shares on the
Record Date of December 29, 2014 shall receive a 20% dividend which
translates to 1 (one) share of USEI common stock for every 5
(shares) shares held by such shareholder. For example, if a
shareholder owns 500,000 shares of USEI common stock at the close
of business on December 29, 2014, that shareholder shall receive
100,000 additional shares of USEI common stock, giving that
shareholder a total of 600,000 shares.
According to Anthony Miller, CEO, "We have
decided to award all of our loyal shareholders with this additional
stock because they have stuck with us through our transitional
phases. Many of our shareholders have held this stock in excess of
6 years, and they along with newer shareholders, will now become
beneficiaries of our anticipated growth. In 2014 we moved into the
cannabis industry and have had some success
(two CBD stores opened and a host of
branded cannabis related products) and we believe that many of the
initiatives we have started this past year will reap rewards in
2015. Management will continue to focus on its energy initiatives
as well in 2015. This firm is an energy company at its core and the
company's oil & gas technologies, our green energy
relationships (biodiesel & hemp) and our strategic partnerships
will continue to become a significant part of our efforts in 2015.
It is our goal in 2015 to split our efforts on both business
segments and management has a significant plan to do this. The
management would like to personally thank all of the shareholders
of record of US Energy Initiatives Corporation, Inc for all of your
support over the last few years, and it is our goal to wake up
every morning to attempt to build the best energy and cannabis firm
that we can; with what we have before us. We are excited about the
directions that we are headed and will continue to press on; till
we reach our goals and objectives... further commented Miller."
About U.S. Energy Initiatives: U.S. Energy
Initiatives Corporation (OTC PINK: USEI) is a diverse energy
firm. USEI and its wholly owned subsidiary USEI
Cannabis' business centers on hemp to energy,
everything cannabis related and developing products and services
for the marketplace. Our Ultimate
Cure & Real McCoy Genuine
Products: we market vapor pens and accessories, topical
ointments, cannabis oils and tinctures all under these same names.
Our focus in the state of Washington is
currently CBD Cannabis however,
we are not just focusing on CBD side of
business (http://www.useicannabis.com/web/washington-partnerships/...
Our online store: http://www.theuccbdshop.com/);we
are actively working to obtain the ability to produce our own
products, own our own recreational dispensary and grow marijuana.
Our goal here is to become an environmentally responsible firm,
marketing our products to our audience to produce significant
revenue and add value for our shareholders. We have very ambitious
goals and objectives for USEI Cannabis and we believe that we will
have a very long presence in Washington and Oregon, and wherever
cannabis is legal. Our objective is to create a foundation that
will be instrumental in our continued efforts to capture our
market-share and create viable products that meet our goals and
objectives for these markets. For more information regarding our
strategies it can be found on the company's website @ www.useicannabis.com/web/.
Cannabidiol -- CBD -- is a compound in cannabis that has
significant medical effects, but does not make people feel "stoned"
and can actually counter the psychoactivity of THC. The reduced
psychoactivity of CBD-rich cannabis may make it an appealing
treatment option for patients seeking anti-inflammatory, anti-pain,
anti-anxiety, anti-psychotic, and/or anti-spasm effects without
disconcerting lethargy or dysphoria. Scientific and clinical
studies underscore CBD's potential as a treatment for a wide range
of conditions, including rheumatoid arthritis, diabetes,
alcoholism, MS, chronic pain, schizophrenia, PTSD,
antibiotic-resistant infections, epilepsy, and other neurological
disorders. CBD has demonstrated neuroprotective and neurogenic
effects, and its anti-cancer properties are currently being
investigated at several academic research centers in the United
States and elsewhere.
DISCLOSURES: "Safe Harbor" This press
release contains forward-looking statements including statements
regarding the timing of the revenue from the partnership and the
partnership's success. The words "believe," "may," "estimate,"
"continue," "anticipate," "intend," "should," "plan," "could,"
"target," "potential," "is likely," "will," "expect" and similar
expressions, as they relate to us, are intended to identify
forward-looking statements. We have based these forward-looking
statements largely on our current expectations and projections
about future events and financial trends that we believe may affect
our financial condition, results of operations, business strategy
and financial needs. Important factors that could cause actual
results to differ from those in the forward looking statements
include consumer reaction to our Cannabis products and new
regulations which affect the distribution of these products.
Further information on our risk factors is contained in our filings
with the OTC Markets. Any forward-looking statement made by us
herein speaks only as of the date on which it is made. Factors or
events that could cause our actual results to differ may emerge
from time to time, and it is not possible for us to predict all of
them. We undertake no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future developments or otherwise, except as may be required by
law.